Literature DB >> 23678072

Easily modified factors contribute to delays in diagnosis of Clostridium difficile infection: a cohort study and intervention.

Sirisha Kundrapu1, Lucy A Jury, Brett Sitzlar, Venkata C K Sunkesula, Ajay K Sethi, Curtis J Donskey.   

Abstract

Although rapid laboratory tests are available for diagnosis of Clostridium difficile infection (CDI), delays in completion of CDI testing are common in clinical practice. We conducted a cohort study of 242 inpatients tested for CDI to determine the timing of different steps involved in diagnostic testing and to identify modifiable factors contributing to delays in diagnosis. The average time from test order to test result was 1.8 days (range, 0.2 to 10.6), with time from order to stool collection accounting for most of the delay (mean, 1.0 day; range, 0 to 10). Several modifiable factors contributed to delays, including not providing stool collection supplies to patients in a timely fashion, rejection of specimens due to incorrect labeling or leaking from the container, and holding samples in the laboratory for batch processing. Delays in testing contributed to delays in initiation of treatment for patients diagnosed with CDI and to frequent prescription of empirical CDI therapy for patients with mild to moderate symptoms whose testing was ultimately negative. An intervention that addressed several easily modified factors contributing to delays resulted in a significant decrease in the time required to complete CDI testing. These findings suggest that health care facilities may benefit from a review of their processes for CDI testing to identify and address modifiable factors that contribute to delays in diagnosis and treatment of CDI.

Entities:  

Mesh:

Year:  2013        PMID: 23678072      PMCID: PMC3697705          DOI: 10.1128/JCM.03142-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  An epidemic, toxin gene-variant strain of Clostridium difficile.

Authors:  L Clifford McDonald; George E Killgore; Angela Thompson; Robert C Owens; Sophia V Kazakova; Susan P Sambol; Stuart Johnson; Dale N Gerding
Journal:  N Engl J Med       Date:  2005-12-01       Impact factor: 91.245

2.  Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant enterococci during treatment of Clostridium difficile-associated disease.

Authors:  Wafa N Al-Nassir; Ajay K Sethi; Yuejin Li; Michael J Pultz; Michelle M Riggs; Curtis J Donskey
Journal:  Antimicrob Agents Chemother       Date:  2008-04-28       Impact factor: 5.191

3.  C. Diff Quik Chek complete enzyme immunoassay provides a reliable first-line method for detection of Clostridium difficile in stool specimens.

Authors:  Criziel D Quinn; Susan E Sefers; Wisal Babiker; Ying He; Romina Alcabasa; Charles W Stratton; Karen C Carroll; Yi-Wei Tang
Journal:  J Clin Microbiol       Date:  2009-12-02       Impact factor: 5.948

4.  Utility of perirectal swab specimens for diagnosis of Clostridium difficile infection.

Authors:  Sirisha Kundrapu; Venkata C K Sunkesula; Lucy A Jury; Ajay K Sethi; Curtis J Donskey
Journal:  Clin Infect Dis       Date:  2012-08-21       Impact factor: 9.079

5.  Comparison of BD GeneOhm Cdiff real-time PCR assay with a two-step algorithm and a toxin A/B enzyme-linked immunosorbent assay for diagnosis of toxigenic Clostridium difficile infection.

Authors:  Elizabeth J Kvach; David Ferguson; Paul F Riska; Marie L Landry
Journal:  J Clin Microbiol       Date:  2009-10-28       Impact factor: 5.948

6.  Reducing delays in the diagnosis and treatment of Clostridium difficile diarrhoea.

Authors:  M B Frenz; A S McIntyre
Journal:  QJM       Date:  2003-08

7.  Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive "bundle" approach.

Authors:  Carlene A Muto; Mary Kathleen Blank; Jane W Marsh; Emanuel N Vergis; Mary M O'Leary; Kathleen A Shutt; Anthony W Pasculle; Marian Pokrywka; Juliet G Garcia; Kathy Posey; Terri L Roberts; Brian A Potoski; Gary E Blank; Richard L Simmons; Peter Veldkamp; Lee H Harrison; David L Paterson
Journal:  Clin Infect Dis       Date:  2007-10-09       Impact factor: 9.079

8.  Does my patient have Clostridium difficile infection?

Authors:  Lance R Peterson; Ari Robicsek
Journal:  Ann Intern Med       Date:  2009-08-04       Impact factor: 25.391

9.  Diagnostic and treatment delays in recurrent Clostridium difficile-associated disease.

Authors:  Danielle Scheurer
Journal:  J Hosp Med       Date:  2008-03       Impact factor: 2.960

Review 10.  Adverse outcomes associated with Contact Precautions: a review of the literature.

Authors:  Daniel J Morgan; Daniel J Diekema; Kent Sepkowitz; Eli N Perencevich
Journal:  Am J Infect Control       Date:  2009-03       Impact factor: 2.918

View more
  5 in total

1.  Clostridium difficile in the Long-Term Care Facility: Prevention and Management.

Authors:  Robin L P Jump; Curtis J Donskey
Journal:  Curr Geriatr Rep       Date:  2015-03

2.  Equivalent Performance of the Cobas® Cdiff Test for Use on the Cobas® Liat® System and the Cobas® 4800 System.

Authors:  Sachin K Garg; Kyle Lu; John Duncan; Lance R Peterson; Oliver Liesenfeld
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2017-12-05

3.  Using Dog Scent Detection as a Point-of-Care Tool to Identify Toxigenic Clostridium difficile in Stool.

Authors:  Maureen T Taylor; Janine McCready; George Broukhanski; Sakshi Kirpalaney; Haydon Lutz; Jeff Powis
Journal:  Open Forum Infect Dis       Date:  2018-08-22       Impact factor: 3.835

4.  Indeterminate tcdB using a Clostridium difficile PCR assay: a retrospective cohort study.

Authors:  Jerome A Leis; Wayne L Gold; John Ng; Zahir Hirji; Dylan R Pillai; George Broukhanski; Paula Raggiunti; Susy Hota; Allison McGeer; Susan M Poutanen
Journal:  BMC Infect Dis       Date:  2013-07-16       Impact factor: 3.090

5.  Point-of-Care Testing for Clostridium Difficile Infection: A Real-World Feasibility Study of a Rapid Molecular Test in Two Hospital Settings.

Authors:  Simon D Goldenberg; Karen N Bisnauthsing; Amita Patel; Anne Postulka; Duncan Wyncoll; Rebekah Schiff; Gary L French
Journal:  Infect Dis Ther       Date:  2014-09-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.